Survival Gains, Savings With Next-Generation Sequencing in NSCLC Survival Gains, Savings With Next-Generation Sequencing in NSCLC

The modeling study shows"clinically meaningful" gains in survival and lower costs with NGS over single-gene testing in metastatic nonsquamous NSCLC.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news